ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition

ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition

Summary: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, with poor prognosis due to late diagnosis and limited treatment options. In this study, we evaluated the expression of ectonucleoside triphosphate diphosphohydrolase 8 (ENTPD8) in HCC tissues and its clinic...

Full description

Saved in:
Bibliographic Details
Main Authors: Si-qi Zhao, Min-jie Chen, Fei Chen, Zhao-feng Gao, Xiao-ping Li, Ling-yu Hu, Hai-ying Cheng, Jin-yan Xuan, Jian-guo Fei, Zheng-wei Song
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:iScience
Subjects:
molecular biology
cell biology
cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004225000793
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items